EntreMed Files for China Arm of its Sarcoma Clinical Trial

06:52 EDT 28 Jun 2013 | ChinaBio Today

EntreMed, a US pharma with a Beijing subsidiary, has filed an application with the CFDA to conduct a clinical trial in China for ENMD-2076, a novel drug that is EntreMed’s lead drug candidate. Currently, the drug is undergoing a Phase II trial ...

Original Article: EntreMed Files for China Arm of its Sarcoma Clinical Trial

NEXT ARTICLE

More From BioPortfolio on "EntreMed Files for China Arm of its Sarcoma Clinical Trial"

Search BioPortfolio:
Advertisement

Relevant Topic

Pharmacy
Latest News Clinical Trials Research Drugs Reports Corporate
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Advertisement

Searches Linking to this Story